| Product Code: ETC13165110 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Oncology Molecular Diagnostic Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Oncology Molecular Diagnostic Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Oncology Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 North America Oncology Molecular Diagnostic Market - Industry Life Cycle |
3.4 North America Oncology Molecular Diagnostic Market - Porter's Five Forces |
3.5 North America Oncology Molecular Diagnostic Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Oncology Molecular Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Oncology Molecular Diagnostic Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.8 North America Oncology Molecular Diagnostic Market Revenues & Volume Share, By Test Location, 2021 & 2031F |
3.9 North America Oncology Molecular Diagnostic Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 North America Oncology Molecular Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Oncology Molecular Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Oncology Molecular Diagnostic Market Trends |
6 North America Oncology Molecular Diagnostic Market, 2021 - 2031 |
6.1 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.1.3 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Prostate Cancer, 2021 - 2031 |
6.1.4 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Colorectal Cancer, 2021 - 2031 |
6.1.5 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Cervical Cancer, 2021 - 2031 |
6.1.6 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Liver Cancer, 2021 - 2031 |
6.1.7 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Lung Cancer, 2021 - 2031 |
6.1.8 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Blood Cancer, 2021 - 2031 |
6.1.9 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Product, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.2.3 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Reagents, 2021 - 2031 |
6.2.4 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Test Location, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.3.3 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Other Establishments, 2021 - 2031 |
6.3.4 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Point of Care, 2021 - 2031 |
6.4 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.4.2 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By PCR, 2021 - 2031 |
6.4.3 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Multiplex, 2021 - 2031 |
6.4.4 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4.5 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By In Situ Hybridization, 2021 - 2031 |
6.4.6 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021 - 2031 |
6.4.7 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Chips and Microarrays, 2021 - 2031 |
6.4.8 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Mass Spectrometry, 2021 - 2031 |
6.4.9 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
7 North America Oncology Molecular Diagnostic Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Oncology Molecular Diagnostic Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Oncology Molecular Diagnostic Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Oncology Molecular Diagnostic Market Revenues & Volume Share, By Product, 2021 & 2031F |
7.3.1 United States (US) Oncology Molecular Diagnostic Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.2 Canada Oncology Molecular Diagnostic Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.3 Rest of North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Test Location, 2021 - 2031 |
7.4.1 United States (US) Oncology Molecular Diagnostic Market, Revenues & Volume, By Test Location, 2021 - 2031 |
7.4.2 Canada Oncology Molecular Diagnostic Market, Revenues & Volume, By Test Location, 2021 - 2031 |
7.4.3 Rest of North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Test Location, 2021 - 2031 |
7.5 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.1 United States (US) Oncology Molecular Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.2 Canada Oncology Molecular Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.3 Rest of North America Oncology Molecular Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6 North America Oncology Molecular Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.1 United States (US) Oncology Molecular Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.2 Canada Oncology Molecular Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.3 Rest of North America Oncology Molecular Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Oncology Molecular Diagnostic Market Key Performance Indicators |
9 North America Oncology Molecular Diagnostic Market - Export/Import By Countries Assessment |
10 North America Oncology Molecular Diagnostic Market - Opportunity Assessment |
10.1 North America Oncology Molecular Diagnostic Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Oncology Molecular Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Oncology Molecular Diagnostic Market Opportunity Assessment, By Product, 2021 & 2031F |
10.4 North America Oncology Molecular Diagnostic Market Opportunity Assessment, By Test Location, 2021 & 2031F |
10.5 North America Oncology Molecular Diagnostic Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.6 North America Oncology Molecular Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Oncology Molecular Diagnostic Market - Competitive Landscape |
11.1 North America Oncology Molecular Diagnostic Market Revenue Share, By Companies, 2022 |
11.2 North America Oncology Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here